Q2 EPS Estimates for Tenet Healthcare Cut by Zacks Research

Tenet Healthcare Co. (NYSE:THC) – Equities researchers at Zacks Research cut their Q2 2026 earnings per share (EPS) estimates for shares of Tenet Healthcare in a report issued on Wednesday, March 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $3.33 per share for the quarter, down from their previous forecast of $3.34. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2026 earnings at $3.08 EPS.

A number of other research firms also recently weighed in on THC. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Morgan Stanley initiated coverage on Tenet Healthcare in a report on Wednesday, March 26th. They set an “overweight” rating and a $165.00 price objective on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $177.00 target price on shares of Tenet Healthcare in a report on Thursday, February 13th. KeyCorp lowered their price target on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Finally, StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and an average price target of $166.41.

Tenet Healthcare Stock Down 0.7 %

NYSE THC opened at $133.55 on Monday. The stock has a market cap of $12.70 billion, a PE ratio of 4.14, a PEG ratio of 1.02 and a beta of 2.06. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare has a twelve month low of $90.03 and a twelve month high of $171.20. The firm has a 50-day simple moving average of $132.49 and a 200 day simple moving average of $141.94.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Insiders Place Their Bets

In related news, Director J Robert Kerrey sold 9,525 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now owns 27,378 shares of the company’s stock, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.93% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the company. New Wave Wealth Advisors LLC bought a new position in Tenet Healthcare in the fourth quarter valued at about $343,000. Swedbank AB boosted its stake in shares of Tenet Healthcare by 100.0% in the 4th quarter. Swedbank AB now owns 40,000 shares of the company’s stock valued at $5,049,000 after purchasing an additional 20,000 shares during the last quarter. Signet Financial Management LLC acquired a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $1,526,000. China Universal Asset Management Co. Ltd. acquired a new position in Tenet Healthcare in the fourth quarter valued at approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Tenet Healthcare in the fourth quarter valued at approximately $5,892,000. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.